Publications

5539 Results

Planning for successful recruitment for cancer trials

Authors
K Anderson;J Probstfield;SM Thomas
Journal / Conference
Controlled Clinical Trials 24(3S)Suppl:102S(#P18)
Year
2003
Research Committee(s)
Prevention and Epidemiology
Study Number(s)
S0000

Challenges of implementing ancillary studies within multi-site clinical trials

Authors
T Chay;P Goodman;J Hartline
Journal / Conference
Controlled Clinical Trials24(3S)Suppl:182S(#P173)
Year
2003
Research Committee(s)
Prevention and Epidemiology
Study Number(s)
S0000

Form and function: PDF+ versus HTML form design

Authors
K Gower;B Kleinman
Journal / Conference
Controlled Clinical Trials 24(3S)Suppl:188A(#P186)
Year
2003
Research Committee(s)
Prevention and Epidemiology
Study Number(s)
S0000

Drug distribution challenges in a multi-site clinical trial

Authors
A Darke;J Vertrees;P Goodman
Journal / Conference
Controlled Clinical Trials 24(3S)Suppl:203S(#P217)
Year
2003
Research Committee(s)
Prevention and Epidemiology
Study Number(s)
S0000

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Authors
A Rosenwald;G Wright;A Wiestner;WC Chan;JM Connors;E Campo;RD Gascoyne;TM Grogan;HK Muller-Hermelink;EB Smeland;M Chiorazzi;JM Giltnane;EM Hurt;H Zhao;L Averett;S Henrickson;L Yang;J Powell;WH Wilson;ES Jaffe;R Simon;RD Klausner;E Montserrat;F Bosch;TC Greiner;DD Weisenburger;WG Sanger;BJ Dave;JC Lynch;J Vose;JO Armitage;RI Fisher;TP Miller;M LeBlanc;G Ott;S Kvaloy;H Holte;H Delabie;LM Staudt
Journal / Conference
Cancer Cell 3:185-197
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Phase II study of pro-MACE CytaBOM with trimethoprim sulfamethoxazole, granulocyte colony stimulating factor (G-CSF) and antiretroviral therapy in patients with AIDS related non-Hodgkin's lymphoma (AIDS-NHL), (S9320)

Authors
LJ Swinnen;E Gaynor;M LeBlanc;MJ Lechowicz;J Unger;TP Miller;TM Grogan;RI Fisher
Journal / Conference
Blood 102(11):(#1462)
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9320

Phase II study of sequential reduction in immunosuppression, interferon alpha-2b, and ProMACE-CytaBOM chemotherapy for post-transplant lymphoproliferative disorder (PTLD) (SWOG/ECOG S9239)

Authors
LJ Swinnen;M LeBlanc;Y Kasamon;T Grogan;L Gordon;TP Miller;RI Fisher
Journal / Conference
Blood 102(11):403a (#1463)
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9239

Frequent alterations of B-catenin gene in gastric cancers with microsatellite instability

Authors
J Wang;T Shepherd;A Lowy;A Noffsinger;G Stemmermann;C Fenoglio-Preiser
Journal / Conference
Proc of the American Association for Cancer Research 44(2nd.ed): #1199
Year
2003
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Detection of gene copy number alterations using a panel of DNA FISH probes in malignant melanoma

Authors
DL Persons;ML Slovak;JA Sosman;D Bobadilla;V Bedell;RJ Tuthill;J Moon;VK Sondak
Journal / Conference
Proc of the American Association for Cancer Research 44:571(#2510)
Year
2003
Research Committee(s)
Melanoma

Recombinant human erythropoietin (EPO) as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study

Authors
RS Lavey;PY Liu;BE Greer;WR Robinson;CC Pui;RB Wynn;ME Conrad;C Jiang;M Markman;DS Alberts
Journal / Conference
Int Journal of Radiation Oncology Bio Phy 57(2) Suppl:S190-S191(#110)
Year
2003
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9318